Single-source vs multi-source drugs: what patients should know about cost, effectiveness, and insurance
Nov 19 2025
Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers in 2026
Explore how FDA Import Alerts block non-compliant drugs, focusing on the 2025 GLP-1 crackdown, Green List requirements, and financial penalties for manufacturers.
